InsiderTrades.com logo
The AI Stock that’s Disrupting Every Industry
From StockEarnings   |   Ad
Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…
Here's the Ticker >>>

SILO Insider Trading

Insider Ownership Percentage: 5.56%
Insider Buying (Last 12 Months): $23,668.16
Insider Selling (Last 12 Months): $0.00

Silo Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Silo Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Silo Pharma Share Price & Price History

Current Price: $1.84
Price Change: ▼ Price Decrease of -0.01 (-0.54%)
As of 05/3/2024 12:16 PM ET

This chart shows the closing price history over time for SILO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Biden to Launch “FedNOW” [Move Your Money Now]
From Priority Gold   |   Ad
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Get your free information kit NOW, before it's too late.

Silo Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2024Eric WeisblumCEOBuy600$1.96$1,176.00175,032View SEC Filing Icon  
4/1/2024Eric WeisblumCEOBuy1,100$1.91$2,101.00174,432View SEC Filing Icon  
3/28/2024Eric WeisblumCEOBuy3,408$1.94$6,611.52173,332View SEC Filing Icon  
12/19/2023Eric WeisblumCEOBuy500$1.63$815.00169,724View SEC Filing Icon  
12/14/2023Eric WeisblumCEOBuy200$1.50$300.00168,324View SEC Filing Icon  
12/7/2023Eric WeisblumCEOBuy324$1.36$440.64168,124View SEC Filing Icon  
12/5/2023Eric WeisblumCEOBuy600$1.39$834.00167,724View SEC Filing Icon  
11/30/2023Eric WeisblumCEOBuy1,000$1.53$1,530.00167,124View SEC Filing Icon  
11/27/2023Eric WeisblumCEOBuy250$1.78$445.00165,124View SEC Filing Icon  
11/22/2023Eric WeisblumCEOBuy400$1.68$672.00164,874View SEC Filing Icon  
11/16/2023Eric WeisblumCEOBuy1,100$1.33$1,463.00158,324View SEC Filing Icon  
5/26/2023Daniel E RyweckCFOBuy1,000$2.13$2,130.005,000View SEC Filing Icon  
5/17/2023Eric WeisblumCEOBuy2,500$2.06$5,150.00157,224View SEC Filing Icon  
12/19/2022Eric WeisblumCEOBuy200$2.68$536.00154,724View SEC Filing Icon  
See Full Table
Have You Seen Elon’s New A.I. Device? (Picture Inside)
From InvestorPlace   |   Ad
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
This strange new device to protect us against that A.I. threat...

SEC Filings (Institutional Ownership Changes) for Silo Pharma (NASDAQ:SILO)

5.58% of Silo Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Silo Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/11/2023Financial Advocates Investment Management44,507$93K0.0%+196.6%1.408%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Silo Pharma logo
Silo Pharma. Inc., a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief. The company's preclinical products include SPC-14 to treat Alzheimer's disease; and SPU-16, a central nervous system homing peptide targeting the central nervous system with indication in multiple sclerosis. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin and ketamine, as well as depression, mental health issues, and neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Read More on Silo Pharma

Today's Range

Now: $1.84
Low: $1.77
High: $1.84

50 Day Range

MA: $1.82
Low: $1.51
High: $2.14

52 Week Range

Now: $1.84
Low: $1.22
High: $3.05

Volume

9,516 shs

Average Volume

175,428 shs

Market Capitalization

$5.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Silo Pharma?

Silo Pharma's top insider investors include:
  1. Eric Weisblum (CEO)
  2. Daniel E Ryweck (CFO)
Learn More about top insider investors at Silo Pharma.
Global crypto currency reset (41 major banks signed up)
From Stansberry Research   |   Ad
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
 Here's everything you need to know.